Cardiff Oncology (CRDF) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CRDF Cardiff Oncology

Watchlist

2.450
-0.050-2.00%

Close Nov 22 16:00 ET

2.480
+0.030+1.22%

Pre 08:56 ET

125.28MMarket Cap-2578P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cardiff Oncology Announces New Patent With Claims for Onvansertib
TipRanksNov 19 08:16 ET
Express News | Cardiff Oncology Inc: Announces New Patent With Claims for Use of Onvansertib in Treating Kras Mutated Mcrc
ReutersNov 19 08:05 ET
Here's Why We're Watching Cardiff Oncology's (NASDAQ:CRDF) Cash Burn Situation
Simply Wall StNov 15 06:17 ET
Cardiff Oncology Reports Positive Q3 2024 Results and Clinical Progress
TipRanksNov 8 23:17 ET
Cardiff Oncology Is Maintained at Buy by HC Wainwright & Co.
Dow JonesNov 8 14:40 ET · Ratings
Express News | Cardiff Oncology Shares Are Trading Lower. The Company Reported Q3 Financial Results
BenzingaNov 8 12:02 ET

Comments

Trytosaveabit

Nov 19 07:08

News

$Cardiff Oncology (CRDF.US)$ Reuters· 2 mins ago
Cardiff Oncology Inc: Announces New Patent With Claims for Use of Onvansertib in Treating Kras Mutated Mcrc

Bigmoney Dreamer

Nov 14 16:26

$Cardiff Oncology (CRDF.US)$

Bigmoney Dreamer

Nov 11 10:03

$Cardiff Oncology (CRDF.US)$ first 🎯6.63 🚀

Bigmoney Dreamer

Nov 9 10:36

$Cardiff Oncology (CRDF.US)$
Risk Assessment
CRDF is assessed as a high-risk investment with a risk level score of 8/10. This elevated risk stems from the company's negative financial position, large operating losses, and heavy reliance on equity financing, which could lead to volatility and rapid changes in stock price. The Biotechnology sector's low appeal further contributes to the stock's risk, limiting investor interest. Short interest is high, suggesting a significant portion of investors ...